Neuropharmacology conferences

Chemistry and neuroscience meet in a French-language programme on brain disorders and treatments. Topics include delivering drugs to the brain, obstacles in neurodegenerative therapy, translational medicine, marine natural products, exposure biomarkers and lysosomal approaches. Afternoon research addresses membranes in Alzheimer’s disease, copper chelators, multifunctional molecules and natural products, followed by a lecture on memory. The programme runs 09:00–17:00 Paris time on 4 November. In-person attendance is free with advance registration by 25 October; lunch depends on capacity, with school groups prioritised.

The congress connects experimental and clinical pharmacology, from identifying therapeutic targets and testing mechanisms in preclinical models to clinical trials, access to treatment and evidence from routine care. Its programme examines synaptic and cellular communication in neurodegeneration, immunometabolism, inflammation, oncology, precision medicine and sex-aware experimental design. Sessions also address drug development, regulatory decisions, artificial intelligence and the sustainability of pharmacological research. Plenary lectures connect unmet needs in oncology to improved care and trace lysosomal calcium signalling from discovery towards clinical applications. Parallel symposia, young-investigator presentations and discussions bring together basic research and translational practice. Times are Europe/Rome (CET, UTC+1). On 25 November, parallel sessions begin at 13:30, the opening ceremony is 15:30–16:00 and the first plenary is 16:00–17:00. Morning sessions begin at 08:30 on 26–28 November. The final plenary is 11:30–12:30 on 28 November, followed by conclusions and awards until 13:00. Standard full-congress fees are EUR 500 for SIF members and EUR 300 for members under 38; academic non-members pay EUR 854, or EUR 488 if under 38, including VAT. Industry non-members pay EUR 1,159, with a higher PayPal rate. Day tickets are available. Shared-room accommodation for eligible non-tenured SIF members under 38 is subject to a waiting list after 16 June. Registration requires a separate congress-platform account; SIF website credentials do not apply.

The meeting uses altered states across evolutionarily distant species to investigate the biological basis of consciousness. Sleep, anaesthesia, hibernation and dissociative states are examined from molecular and circuit mechanisms through animal and human behaviour. Discussions connect experimental neuroscience with disorders of consciousness, recovery after general anaesthesia and the therapeutic potential of anaesthetic- and psychedelic-induced states. The format emphasizes unpublished findings, extended discussion, posters and interactions between trainees and established researchers. Attendance applications are reviewed and capacity may fill before the application deadline.